Dr. Jett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Retired
Napa, CA 94559Phone+1 303-388-4461- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1976 - 1978- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1974 - 1976
Spectrum Health/Michigan State UniversityInternship, Transitional Year, 1973 - 1974
University of Missouri-Columbia School of MedicineClass of 1973
Certifications & Licensure
CO State Medical License 2010 - 2025
AZ State Medical License 1989 - 2018
MN State Medical License 1975 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer Start of enrollment: 1998 Apr 01
- Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer Start of enrollment: 1999 Nov 01
- Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Start of enrollment: 2001 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Letter to Editor: Interpretation and Application of the Likelihood Ratio to Clinical Practice in Thoracic OncologySteven C. Springmeyer, James R. Jett> ;Journal of Bronchology & Interventional Pulmonology. 2021 Sep 9
- 9 citationsAssessment of Integrated Classifier’s Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmon...Nichole T. Tanner, Steven C. Springmeyer, Alex Porter, James R. Jett, Peter J. Mazzone, Anil Vachani, Gerard A. Silvestri> ;Chest. 2021 Mar 1
- Managing Lung Nodules Using Telemedicine and Molecular Biomarkers During the COVID-19 Pandemic.Steven C. Springmeyer, James R. Jett, Krish Bhadra, Fayez Kheir, Adnan Majid> ;Chest. 2020 Oct 1
- Join now to see all
Other
- Cannabis Use, Lung Cancer, and Related IssuesJames Jett, MD, Journal of Thoracic Oncology
https://www.doximity.com/articles/7b40eb75-bcb7-4d94-bf3b-c012b41b7539
UpToDate, Wolters Kluwer Health - 2013-03-28
Authored Content
- Cannabis Use, Lung Cancer, and Related IssuesFebruary 2018
Press Mentions
Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody TestJune 15th, 2021
Biodesix Names Dr. James Jett Chief Medical OfficerOctober 8th, 2019
Oncimmune Demonstrates Clinical Utility of Early Lung Cancer Detection Test at IASLC World Conference on Lung CancerSeptember 25th, 2018- Join now to see all
Grant Support
- Lung CancerNational Cancer Institute2001–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
